Literature DB >> 9461522

Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.

T E Hebert1, T P Loisel, L Adam, N Ethier, S S Onge, M Bouvier.   

Abstract

We have recently demonstrated that wild-type beta2-adrenergic receptors (beta2AR) form homodimers and that disruption of receptor dimerization inhibits signalling via Gs [Hebert, Moffett, Morello, Loisel, Bichet, Barret and Bouvier (1996) J. Biol. Chem. 271, 16384-16392]. Here taking advantage of the altered functional properties of a non-palmitoylated, constitutively desensitized mutant beta2AR (C341Gbeta2AR), we sought to study whether physical interactions between mutant and wild-type beta2AR expressed in Sf9 cells could occur and have functional consequences. Using metabolic labelling with [3H]palmitate and co-immunoprecipitation we demonstrated the existence of heterodimerization between wild-type and C341Gbeta2AR. Furthermore, we show that, in co-expression experiments, wild-type receptors have a dominant positive effect resulting in the functional complementation of C341Gbeta2AR. Indeed, when expressed alone, the mutant C341G receptor displays altered functional characteristics in that (1) the response of the receptor to agonist is reduced as compared to the wild-type receptor and (2) the desensitization of the receptor in response to prolonged exposure to agonist is minimal. In contrast, when C341G and the wild-type beta2AR were expressed together, both the response to agonist and subsequent desensitization (at a constant level of total receptor) were equivalent to the wild-type beta2AR expressed alone. This dominant positive effect was also seen when C341G was co-expressed with a second receptor mutant in which the two protein kinase A phosphorylation sites (S261, 262, 345, 346A beta2AR) were mutated. Taken together these data suggest that intermolecular interactions between receptors may have both functional and structural implications for G-protein-mediated signalling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461522      PMCID: PMC1219139          DOI: 10.1042/bj3300287

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation.

Authors:  T E Hebert; S Moffett; J P Morello; T P Loisel; D G Bichet; C Barret; M Bouvier
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

2.  Agonist stimulation increases the turnover rate of beta 2AR-bound palmitate and promotes receptor depalmitoylation.

Authors:  T P Loisel; L Adam; T E Hebert; M Bouvier
Journal:  Biochemistry       Date:  1996-12-10       Impact factor: 3.162

3.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization.

Authors:  W P Hausdorff; M Bouvier; B F O'Dowd; G P Irons; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

4.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation.

Authors:  J Ibarrondo; D Joubert; M N Dufour; A Cohen-Solal; V Homburger; S Jard; G Guillon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Palmitoylated cysteine 341 modulates phosphorylation of the beta2-adrenergic receptor by the cAMP-dependent protein kinase.

Authors:  S Moffett; L Adam; H Bonin; T P Loisel; M Bouvier; B Mouillac
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

8.  Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.

Authors:  C Monnot; C Bihoreau; S Conchon; K M Curnow; P Corvol; E Clauser
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

9.  Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.

Authors:  K A Wreggett; J W Wells
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

10.  Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis.

Authors:  M B Mixon; E Lee; D E Coleman; A M Berghuis; A G Gilman; S R Sprang
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  17 in total

Review 1.  Genetic polymorphisms of adrenergic receptors.

Authors:  E M Garland; I Biaggioni
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

2.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 3.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

4.  Detection of pairwise residue proximity by covariation analysis for 3D-structure prediction of G-protein-coupled receptors.

Authors:  Wataru Nemoto; Takashi Imai; Takuya Takahashi; Takeshi Kikuchi; Norihisa Fujita
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

5.  Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.

Authors:  F Cogé; S P Guenin; A Renouard-Try; H Rique; C Ouvry; N Fabry; P Beauverger; J P Nicolas; J P Galizzi; J A Boutin; E Canet
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 6.  Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms.

Authors:  Gary P Anderson
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

7.  Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.

Authors:  Ming Lu; Tong Wang; Qingshang Yan; Xinbo Yang; Ke Dong; Mark A Knepper; WenHui Wang; Gerhard Giebisch; Gary E Shull; Steven C Hebert
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

8.  Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.

Authors:  L Joos; T D Weir; J E Connett; N R Anthonisen; R Woods; P D Paré; A J Sandford
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

9.  Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors.

Authors:  Shin-ichiro Miura; Yoshino Matsuo; Yoshihiro Kiya; Sadashiva S Karnik; Keijiro Saku
Journal:  Biochem Biophys Res Commun       Date:  2009-11-05       Impact factor: 3.575

10.  Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.

Authors:  Rebeca E Nuñez; Sabzali Javadov; Nelson Escobales
Journal:  Pflugers Arch       Date:  2018-05-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.